Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Emotional Stimulation on the Stress Levels of Healthy Persons

This study has been completed.
Sponsor:
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01187797
First received: August 9, 2010
Last updated: October 22, 2010
Last verified: August 2010
  Purpose

The purpose of this study is to evaluate the effects of a short-term emotional stimulation on the mood of healthy persons.


Condition Intervention Phase
Depression
Somatization Disorder
Anger
Anxiety
Other: Emotional stimulation
Phase 1
Phase 2

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluation of the Effects of a Body-centered Emotional Stimulation in Healthy Persons

Resource links provided by NLM:


Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Depression [ Time Frame: After 10 days ] [ Designated as safety issue: No ]
    Depression scores will be evaluated with the BDI

  • Somatization [ Time Frame: After 10 days ] [ Designated as safety issue: No ]
    Somatization will be assessed with the SOMS7 questionnaire


Enrollment: 21
Study Start Date: August 2010
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intervention Other: Emotional stimulation
Increase of the physical correlates of an emotion

Detailed Description:

The trial assesses the effects of a emotion-centered stimulation on the mood of healthy persons. The outcomes will be evaluated with standard questionnaires.

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 18 to 45
  • Ability to speak German

Exclusion Criteria:

  • Physical or psychiatric disorders
  • Consume of drugs or alcohol 24 previous to the test
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01187797

Locations
Germany
Charité Universitätsmedizin Berlin
Berlin, Germany, 12200
Sponsors and Collaborators
Charite University, Berlin, Germany
Investigators
Principal Investigator: fernando Dimeo, MD Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: Fernando Dimeo, Charie Universitätsmedizin Berlin
ClinicalTrials.gov Identifier: NCT01187797     History of Changes
Other Study ID Numbers: EA408109
Study First Received: August 9, 2010
Last Updated: October 22, 2010
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Depression
Somatoform Disorders
Behavioral Symptoms
Mental Disorders

ClinicalTrials.gov processed this record on November 20, 2014